SCHEMBL23769102

SCHEMBL23769102

C[C@H]1c2ccc(C(=O)O)cc2N(Cc2ccccc2)C(=O)N1C

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
STING1 Q86WV6 1/20 0.50
MAPT P10636 1/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 2/20 0.49
HPGD P15428 1/20 0.49
HDAC6 Q9UBN7 1/20 0.46
POLB P06746 2/20 0.44
PARK7 Q99497 1/20 0.44
PRKAG1 P54619 3/20 0.43
PRKAA2 P54646 3/20 0.43
PRKAB1 Q9Y478 3/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
CACNA1G O43497 1/20 0.42
CACNA1H O95180 1/20 0.42
CACNA1I Q9P0X4 1/20 0.42
EP300 Q09472 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29256261 1.00 STING1 (0.50) STING1MAPTKMT2AMEN1HPGD
SCHEMBL23769104 0.91 STING1 (0.48) STING1MAPTKMT2AMEN1HDAC6
SCHEMBL25138410 0.91 STING1 (0.48) STING1MAPTKMT2AMEN1HDAC6
SCHEMBL23769101 0.89 STING1 (0.49) STING1MAPTKMT2AMEN1HDAC6
SCHEMBL23769096 0.89 STING1 (0.49) STING1MAPTKMT2AMEN1HDAC6
SCHEMBL30128427 0.87 STING1 (0.61) STING1MAPTKMT2AMEN1HDAC6
SCHEMBL21932185 0.87 STING1 (0.61) STING1MAPTKMT2AMEN1HDAC6
SCHEMBL23768984 0.85 STING1 (0.45) STING1MAPTKMT2AMEN1HPGD
SCHEMBL21932216 0.82 STING1 (0.73) STING1MAPTKMT2AMEN1POLB
SCHEMBL21932350 0.82 STING1 (0.73) STING1MAPTKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-B Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2025-02-11 CN disclosed
EP-4384267-A1 SMALL MOLECULE STING ANTAGONISTS Curadev Pharma Pvt. Ltd. (IN) 2024-06-19 EP disclosed
CN-118159535-A Small molecule STING antagonists 库拉德夫制药私人有限公司 2024-06-07 CN disclosed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
WO-2023017451-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-02-16 WO disclosed
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 CN disclosed
WO-2021161230-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS STING1 1/4885MAPT 3716/4885KMT2A 4579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.